about
MicroRNA modulation of cholesterol homeostasisMPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile.Effects of Long-Term Supplementation of Blue-Green Algae on Lipid Metabolism in C57BL/6J mice.Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetesHigh glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation.Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients.Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome.Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.Polymorphisms in FADS1 and FADS2 alter plasma fatty acids and desaturase levels in type 2 diabetic patients with coronary artery disease.Increased carotid intima-media thickness in Brazilian adolescents with type 1 diabetes mellitusImpact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines.Cardiovascular risk in double diabetes mellitus--when two worlds collide.Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes.Metabolic crosstalk between host and pathogen: sensing, adapting and competing.Impact of predictors upon the reduction of lipid parameters in family medicine practice.The relationships between serum fructosamine concentrations and lipid profiles in community-dwelling adults.The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors.Lowering low-density lipoprotein cholesterol by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?
P2860
Q27026071-60DCA94A-F023-4BA5-9C3A-3076938FF656Q33892898-9E5025D0-DD6F-4AE2-A296-C916091494A4Q34987299-7F9477B6-E3FB-408B-B100-F8C3C09AC31FQ36334878-1B95C48C-4D56-44E5-93AB-01444754BA86Q36386345-EE9178E7-178C-4F33-812C-48EFC30B7CA1Q36449733-F338754C-E9BB-4F83-9450-ABBC17F856E1Q36512376-B2D46B57-1581-464D-A774-A36CADEE2CBEQ36623024-50F030AD-0A3D-49C0-8B13-2EABE6B9FE90Q36714299-43674A45-F80C-47B5-A655-F767A8342748Q37410462-FB1C699B-459C-4F7E-B5CF-2D73A6987D35Q37424006-DAEFC56E-610C-4FF2-A6B8-6F0A157A9A40Q37964753-FA8A3B96-A7EF-49D2-9FBD-BA5B9095E508Q37998114-A6DDBE8E-B6B9-40A7-82F1-CDE2618AB79AQ38001360-6314991E-605F-42FD-9155-8F48B270DEB1Q38039980-073E62B0-9A75-4319-88E9-9A47CAD70114Q38763262-C5B394C9-122E-4A21-85D0-EC52D9C0C5D3Q38934060-57297756-D0A0-4CBD-8C68-B834881D1AC9Q41191722-77C03144-6379-495D-B93E-92722D2C974EQ51132410-D6602028-AF02-4268-B90C-3C077629409BQ54942141-8CECF8D2-16B9-4C61-A7EE-C4C2153B8113
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid control in patients with diabetes mellitus.
@en
Lipid control in patients with diabetes mellitus.
@nl
type
label
Lipid control in patients with diabetes mellitus.
@en
Lipid control in patients with diabetes mellitus.
@nl
prefLabel
Lipid control in patients with diabetes mellitus.
@en
Lipid control in patients with diabetes mellitus.
@nl
P2860
P356
P1476
Lipid control in patients with diabetes mellitus.
@en
P2093
D John Betteridge
P2860
P304
P356
10.1038/NRCARDIO.2011.23
P407
P577
2011-03-15T00:00:00Z